Search
Birch bark extract
go.drugbank.com/drugs/DB16536ApprovedInvestigational(white birch), although hybrids of both species are used as well. … [L42365,L42370] Filsuvez, one of these two formulations, is approved for the treatment of partial thickness wounds in patients with epidermolysis bullosa (EB), a rare group of hereditary disorders of the
Categories: Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 Enzyme InhibitorsFurvina
go.drugbank.com/drugs/DB16547ExperimentalFurvina is marketed in Cuba as Dermofural®, an ointment containing G1 as the only active principle ingredient. It is used to treat dermatological infections.[A228063] … Furvina (G1) is an antimicrobial agent active against Gram-positive and Gram-negative bacteria, yeasts, and filamentous fungi.
Synonyms: 1-(5-Bromofur-2-yl)-2-bromo-2-nitroethene, 2-Bromo-5-(2-bromo-2-nitrovinyl)furanCategories: Heterocyclic Compounds, 1-RingLactobacillus paracasei
go.drugbank.com/drugs/DB16551InvestigationalSynonyms: L. paracaseiMixtures: RisaQuad-2Tetramisole
go.drugbank.com/drugs/DB16561InvestigationalTetramisole is an anthelmintic agent.[A275223]
Categories: Heterocyclic Compounds, 1-RingFuraltadone
go.drugbank.com/drugs/DB16567InvestigationalSynonyms: (±)-5-(MORPHOLINOMETHYL)-3-((5-NITROFURFURYLIDENE)AMINO)-2-OXAZOLIDINONECategories: Heterocyclic Compounds, 1-RingPoliomyelitis virus type 1 (live, attenuated)
go.drugbank.com/drugs/DB16578InvestigationalSynonyms: Poliomyelitis virus type 1, LS - c2ab strain, Poliomyelitis virus type 1 (live, attenuated)Mixtures: ไบวาเลนท์ โอรัล โปลิโอ วัคซีน ทัยป์ 1 และ 3, วัคซีนป้องกันโปลิโอสองสายพันธุ์ (สายพันธุ์ 1 และ 3) ชนิดรับประทานAfimetoran
go.drugbank.com/drugs/DB16580InvestigationalAfimetoran is an immunomodulator and an antagonist of toll-like receptors 7 and 8. … [L32018, L32023] It is also is under investigation in clinical trial NCT04269356 (Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986256 in Healthy Male
Almonertinib
go.drugbank.com/drugs/DB16640ApprovedInvestigationalAlmonertinib is a third-generation EGFR tyrosine kinase inhibitor targeting EGFR-sensitizing and T790M resistance mutations. … [A231859, A231864, A231869] Unlike other third-generation EGFR TKIs, almonertinib is a pyrimidine-based drug that forms a covalent bond to the binding site of the EGFR tyrosine kinase domain.
Synonyms: 2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, N-[5-[[4-(1-Cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-2-propenamideCategories: MATE 1 Inhibitors, P-glycoprotein inhibitorsSugemalimab
go.drugbank.com/drugs/DB16641ApprovedInvestigationalit to have a better safety profile through avoiding unwanted attack of T-cells. … Sugemalimab is a fully human, full-length anti-programmed death-ligand 1 (PD-L1) monoclonal antibody (of the IgG4 isotype) discovered by CStone Pharmaceuticals.
Categories: PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors